Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond

ISSN： 1024-5332

Source： Hematology, Vol.10, Iss.1, 2005-09, pp. : 215-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocyte Function in Chronic Myeloproliferative Disorders

By Wolach B. Gavrieli R. Manor Y. Beutler M.E.

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 4, 1998-12 ,pp. : 544-551

Academic Press

Access to resources Recommend Favorite

Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?

Current Stem Cell Research & Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 253-263

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

By Basquiera Ana L. Soria Néstor W. Ryser Ricardo Salguero Miriam Moiraghi Beatriz Sackmann Federico Sturich Ana G. Borello Adriana Berretta Adriana Bonafé Miriam Barral José Moreno Palazzo Emilio D. García Juan J.

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 323-330

Maney Publishing

Access to resources Recommend Favorite

Hemopoiesis in Ph-Negative Chronic Myeloproliferative Disorders

Current Stem Cell Research & Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 154-160

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Markers in Myeloproliferative Disorders: From Classification to Prognosis?

By Pahl Heike L.

Hematology, Vol. 8, Iss. 4, 2003-08 ,pp. : 199-209

Maney Publishing

Access to resources Recommend Favorite